J.P. Morgan Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Announces Target Price $70

Moomoo NewsFeb 25 06:31 ET · Ratings

J.P. Morgan Sticks to Its Buy Rating for Springworks Therapeutics (SWTX)

TipRanksFeb 25 06:18 ET · Ratings

SpringWorks Therapeutics Insider Sold Shares Worth $2,866,534, According to a Recent SEC Filing

MT NewswiresFeb 25 03:34 ET

Assessing SpringWorks Therapeutics: Insights From 6 Financial Analysts

BenzingaFeb 24 09:01 ET

Why SpringWorks Therapeutics, Inc. (SWTX) Is the Best Performing Pharma Stock So Far in 2025

Yahoo FinanceFeb 23 15:17 ET

Guggenheim Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Cuts Target Price to $77

Moomoo NewsFeb 22 06:34 ET · Ratings

SpringWorks Therapeutics Analyst Ratings

BenzingaFeb 21 13:27 ET · Ratings

H.C. Wainwright Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $74

Moomoo NewsFeb 21 11:31 ET · Ratings

SpringWorks' Q4 Loss Wider Than Expected, Revenues Beat Estimates

Zacks Feb 21 09:55 ET

A Quick Look at Today's Ratings for SpringWorks Therapeutics(SWTX.US), With a Forecast Between $63 to $87

Moomoo NewsFeb 21 08:00 ET · Ratings

Express News | SpringWorks Therapeutics Inc : Guggenheim Cuts Target Price to $77 From $78

ReutersFeb 21 06:47 ET

Here's Why We're Not At All Concerned With SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

Simply Wall StFeb 21 06:22 ET

Subdued Growth No Barrier To SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) With Shares Advancing 65%

Simply Wall StFeb 21 05:27 ET

SpringWorks Therapeutics Reports Strong 2024 Performance

TipRanksFeb 20 23:33 ET

Analysts Are Bullish on These Healthcare Stocks: Aura Biosciences Inc (AURA), Springworks Therapeutics (SWTX)

TipRanksFeb 20 10:50 ET · Ratings

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Thursday

MT NewswiresFeb 20 09:10 ET

SpringWorks Therapeutics Jumps After Results, Conference Call Cancellation

Seeking AlphaFeb 20 08:56 ET

Springworks Therapeutics Q4 Net Loss Narrows

MT NewswiresFeb 20 07:00 ET

SpringWorks Therapeutics | 10-K: FY2024 Annual Report

SECFeb 20 06:56 ET · Announcements

SpringWorks Therapeutics | 8-K: SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates

SECFeb 20 06:51 ET · Announcements